山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (3): 95-96.doi: 10.6040/j.issn.1671-7554.0.2015.1139
• • 上一篇
姚铁柱,马景涛,郭丽敏
中图分类号:
| [1] Polk A, Vaage-nilsen M, Vistisen K, et al. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors[J]. Cancer Treat Rev, 2013, 39(8): 974-998. [2] Meydan N, Kundak I, Yavuzsen T, et al. Cardiotoxicity of de gramonts regimen: incidence, clinical characteristics and long-term follow-up[J]. Jpn J Clin Oncol, 2005, 35(5): 265-270. [3] Saif MW, Sjaj MM, Sjaj AR. Fluoropyrimidime-associated cardiotoxicity: revisited[J]. Expert Opim Drug Saf, 2009, 8(2): 191-202. [4] Saif M, Shah M, Shah A. Fluoropyrimidine-associated cardiotoxicity: revisited[J]. Expert Opin Drug Saf, 2009, 8(2): 191-202. [5] Talapatra K, Rajesh I, Rajesh B, et al.Transient asym-ptomatic bradycardia in patients with infusional 5-fluroruracil[J]. J Cancer Res Ther, 2007, 3(3): 169-171. [6] Kosmas C, Kallistratos M, Kopterides P, et al. Cardiotoxicity of fluoropyrimidines in different schedulesof administration: a prospective study[J]. J Cancer ResClin Oncol, 2008, 134(1): 75-82. [7] Paiva CE, Paiva BS, Garita R, et al. Acute coronary syndrome asso-ciated with continuous 5-Fluorouracil infusion in a patient with metastatic colorectal cancer-a case report with a discussion on this clinical dilemma[J]. J Gastrointest Cancer, 2009, 40(3-4): 133-137. [8] 孙芳毅,王书彩.5-氟尿嘧啶化疗诱发心绞痛发作1 例分析[J].中国肿瘤临床,2012,39(22): 1868-1868. [9] Akao M, Teshima Y, Marbán E. Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes[J]. J Am Coll Cardiol, 2002, 40(4): 803-810. [10] Matsubara T, Minatoguchi S, Matsuo H, et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease[J]. J Am Coll Cardiol, 2000, 35(2): 345-351. [11] 万凯化,高菁,付辉政,等.参麦注射液致349 例不良反应病例报告分析[J].中国药物滥用防治杂志,2014,20(2): 71-73. WAN Kaihua, GAO Jing, FU Huizheng, et al. Analysis of 349 Cases of Adverse Drug reactions/Events Induced by Shenmai Injection[J]. Chinese Journal of Drug Abuse Prevention and Treatment, 2014, 20(2):71-73. |
| [1] | 梁丽宁,钟霞,季宪飞,胡浩然,朱芳芳,陈吉彬,陈茜茜,商德亚. 尼可地尔后适应对猪心脏骤停后心脑肾缺血再灌注损伤的保护作用[J]. 山东大学学报（医学版）, 2017, 55(10): 46-51. |
| [2] | 王尧, 陈艳红, 陈宏. 结肠癌患者外周血DPYD基因多态性与5-FU敏感性和毒副作用相关性分析[J]. 山东大学学报（医学版）, 2014, 52(S1): 18-21. |
| [3] | 唐振旺. 不稳定型心绞痛介入治疗后基质金属蛋白酶9的表达改变对预后的影响[J]. 山东大学学报(医学版), 2012, 50(2): 120-. |
| [4] | 李秀芹1,2,3，卜培莉1,2. 血浆网膜素-1和白介素-18水平与冠心病的关系[J]. 山东大学学报(医学版), 2012, 50(10): 86-89. |
| [5] | 褚倩倩1，许刚2，任桂杰1，徐霞1，胡中一1，刘永青1，苑辉卿1，田克立1. 过氧化物酶体增殖物激活受体γ激动剂对增强人结肠癌化疗敏感性的作用[J]. 山东大学学报(医学版), 2012, 50(1): 66-71. |
| [6] | 张玉，伊永亮，余玫，魏敏，高海青. 应用心脏远程监护技术分析静息性心肌缺血[J]. 山东大学学报(医学版), 2012, 50(1): 94-. |
| [7] | 李玉生，黄黎，吕其军，余永勤. 干扰素α-2b联合5-氟尿嘧啶对人肝癌细胞生物学行为的影响[J]. 山东大学学报(医学版), 2011, 49(9): 48-. |
| [8] | 张栋1，李翠静2，李林军1，席延卫1，黄桂华1. pH依赖-时滞型5-FU微丸大鼠结肠定位释药研究[J]. 山东大学学报(医学版), 2010, 48(12): 46-50. |
| [9] | 刘黎明,丁士芳,王青,高巍,张运,周聊生,李继福 . 梗死前心绞痛有益作用影响因素的临床研究[J]. 山东大学学报(医学版), 2007, 45(4): 348-352. |
| [10] | 丁印鲁,付勤烨,唐思锋,王静源,张建良,李占元,李兆亭 . 血管生成抑制剂SU6668联合5-Fu对人结肠癌裸鼠移植瘤肝转移的影响[J]. 山东大学学报(医学版), 2007, 45(2): 168-170. |
|
||
